| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.24B | — | +9.4% |
| R&D Expense | $101.0M | — | +17.4% |
| SG&A Expense | $544.0M | — | -3.4% |
| Operating Income | $33.0M | — | +139.8% |
| Interest Expense | $97.0M | — | +3.2% |
| Pre-tax Income | -$64.0M | — | +64.4% |
| Income Tax | $6.0M | — | -80.6% |
| Net Income | -$71.0M | — | +66.5% |
| EPS (Basic) | -$0.20 | — | +66.7% |
| EPS (Diluted) | -$0.20 | — | +66.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $268.0M | -30.0% | +32.7% |
| Accounts Receivable | $1.11B | -9.4% | +9.8% |
| Inventory | $977.0M | +0.1% | -5.2% |
| Current Assets | $2.78B | -6.8% | +3.0% |
| Total Assets | $13.78B | -1.7% | +2.6% |
| Current Liabilities | $1.82B | -5.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $32.0M | — | +228.0% |
| Capital Expenditures | $100.0M | — | -9.1% |
| Investing Cash Flow | -$130.0M | — | -12.1% |
| Financing Cash Flow | -$20.0M | — | -164.5% |
| Free Cash Flow | -$68.0M | — | +49.6% |
| +5.4% |
| Long-term Debt | $5.04B | -0.2% | +4.3% |
| Total Liabilities | $7.33B | -2.3% | +4.8% |
| Stockholders' Equity | $6.38B | -1.1% | +0.3% |